Fig. 7From: CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancerA schematic diagram illustrates the action of CMTM6 in trastuzumab resistance of BC. CMTM6 promotes trastuzumab resistance by inhibiting HER2 ubiquitination and degradation in HER2+ BCBack to article page